A study conducted by the Alimentary Pharmacology and Therapeutics has found that the clinical characteristics, including gastrointestinal symptoms, of COVID‐19 in IBD patients, and to assess the risk of COVID‐19 in IBD. Researchers studied IBD patients with laboratory‐confirmed COVID‐19. Age‐adjusted cumulative incidences were compared with the general population in the Madrid region. Through April 8, […]
The post Study Claims Patients with Crohn’s Disease at Not At Higher Risk for COVID-19 Complications appeared first on Shore News Network.
http://dlvr.it/RWC3vp
http://dlvr.it/RWC3vp
Comments
Post a Comment